The glutamate/cystine xCT antiporter antagonizes glutamine metabolism and reduces nutrient flexibility
The factors that limit the nutrient flexibility of cells remain largely unknown. Here, the authors identify the glutamate/cysteine antiporter xCT in a genetic screen for glucose dependency and show it determines the ability of cells to survive under conditions of low glucose by limiting the utilizat...
Guardado en:
Autores principales: | Chun-Shik Shin, Prashant Mishra, Jeramie D. Watrous, Valerio Carelli, Marilena D’Aurelio, Mohit Jain, David C. Chan |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ffc32426233347f1b087b7734c74c44d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Analysis of DNA methylation associates the cystine–glutamate antiporter SLC7A11 with risk of Parkinson’s disease
por: Costanza L. Vallerga, et al.
Publicado: (2020) -
Cystine–glutamate antiporter deletion accelerates motor recovery and improves histological outcomes following spinal cord injury in mice
por: Lindsay Sprimont, et al.
Publicado: (2021) -
Novel antibiofilm chemotherapies target nitrogen from glutamate and glutamine
por: Tal Hassanov, et al.
Publicado: (2018) -
Deep Learning-based Inaccuracy Compensation in Reconstruction of High Resolution XCT Data
por: Emre Topal, et al.
Publicado: (2020) -
Post-inflammatory behavioural despair in male mice is associated with reduced cortical glutamate-glutamine ratios, and circulating lipid and energy metabolites
por: Shi Yu Chan, et al.
Publicado: (2020)